Skip to main content

ORIGINAL RESEARCH article

Front. Microbiol.
Sec. Antimicrobials, Resistance and Chemotherapy
Volume 15 - 2024 | doi: 10.3389/fmicb.2024.1447301
This article is part of the Research Topic Exploring the Depths: Marine-Derived Antimicrobials as New Frontiers in Combating Antimicrobial Resistance View all articles

Trematocine-derived peptides from the Antarctic fish Trematomus bernacchii: potent antibacterial agents against ESKAPE pathogens

Provisionally accepted
Damiano Squitieri Damiano Squitieri 1Federica Massaro Federica Massaro 2Monica M. Graziano Monica M. Graziano 2Stefano Borocci Stefano Borocci 2,3Margherita Cacaci Margherita Cacaci 1,4Maura Di Vito Maura Di Vito 1Fernando Porcelli Fernando Porcelli 2Roberto Rosato Roberto Rosato 1Francesca Ceccacci Francesca Ceccacci 3MAURIZIO SANGUINETTI MAURIZIO SANGUINETTI 1,4Francesco Buonocore Francesco Buonocore 2*Francesca Bugli Francesca Bugli 1,4*
  • 1 Department of Basic Biotechnological Sciences, Intensivological and Perioperative Clinics, Catholic University of the Sacred Heart, Rome, Lazio, Italy
  • 2 Department for Innovation in Biological, Agri-food and Forestry Systems, University of Tuscia, Viterbo, Lazio, Italy
  • 3 Institute for Biological Systems of Italian National Research Council (ISB-CNR), Secondary Office 12 of Rome-Reaction Mechanisms c/o Department of Chemistry, La Sapienza University of Rome, Rome, Italy
  • 4 Agostino Gemelli University Polyclinic (IRCCS), Rome, Lazio, Italy

The final, formatted version of the article will be published soon.

    Introduction This study investigated the interaction with membrane mimetic systems (LUVs), bacterial membranes, the CD spectra, and the bactericidal activity of two designed trematocine mutants, named Trem-HK and Trem-HSK. Mutants were constructed from the scaffold of Trematocine (Trem), a natural 22-amino acid AMP from the Antarctic fish Trematomus bernacchii, aiming to increase their positive charge.The selectivity of the designed AMPs towards bacterial membranes was improved compared to Trematocine, verified by their interaction with different LUVs and their membranolytic activity. Additionally, their α-helical conformation was not influenced by the amino acid substitutions. Our findings revealed a significant enhancement in antibacterial efficacy against ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacteriaceae family) pathogens for both Trem-HK and Trem-HSK.Results Firstly, we showed that the selectivity of the two new designed AMPs towards bacterial membranes was greatly improved compared to Trematocine, verifying their interaction with different LUVs and their membranolytic activity. We determined that their -helical conformation was not influenced by the amino acid substitutions. We characterized the tested bacterial collection for resistance traits to different classes of antibiotics. The minimum inhibitory and bactericidal concentration (MIC and MBC) values of the ESKAPE collection were reduced by up to 80% compared to Trematocine. The bactericidal concentrations of Trematocine mutants showed important membranolytic action, evident by scanning electron microscopy, on all tested species. We further evaluated the cytotoxicity and hemolytic activity of the mutants. At 2.5 μM concentration, both mutants demonstrated low cytotoxicity and hemolysis, indicating selectivity towards bacterial cells. However, these effects increased at higher concentrations. Discussion Assessment of in vivo toxicity using the Galleria mellonella model revealed no adverse effects in larvae treated with both mutants, even at concentrations up to 20 times higher than the lowest MIC observed for Acinetobacter baumannii, suggesting a high potential safety profile for the mutants.This study highlights the significant improvement in antibacterial efficacy achieved by increasing the positive charge of Trem-HK and Trem-HSK. This improvement was reached at the cost of reduced biocompatibility. Further research is necessary to optimize the balance between efficacy and safety for these promising AMPs.

    Keywords: antimicrobial peptides (AMP), Antimicrobial resistance (AMR), ESKAPE pathogens, Membranolytic agents, Multi-drug resistant (MDR) bacteria

    Received: 11 Jun 2024; Accepted: 18 Jul 2024.

    Copyright: © 2024 Squitieri, Massaro, Graziano, Borocci, Cacaci, Di Vito, Porcelli, Rosato, Ceccacci, SANGUINETTI, Buonocore and Bugli. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Francesco Buonocore, Department for Innovation in Biological, Agri-food and Forestry Systems, University of Tuscia, Viterbo, 01100, Lazio, Italy
    Francesca Bugli, Agostino Gemelli University Polyclinic (IRCCS), Rome, 00168, Lazio, Italy

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.